Morgan Stanley Call 275 CHTR 20.0.../ DE000ME88XQ5 /
24/06/2024 08:03:00 | Var.+0.05 | Denaro08:26:36 | Lettera08:26:36 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.41EUR | +3.68% | 1.41 Quantità in denaro: 2,500 |
1.48 Quantità in lettera: 2,500 |
Charter Communicatio... | 275.00 USD | 20/09/2024 | Call |
GlobeNewswire
08:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
08:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
07:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
07:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
07:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
06:20
China's Hangzhou empowers urban development with world-class power supply reliability
GlobeNewswire
03:00
SALESFORCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Salesforce, Inc. on Behalf of Salesfo...